Long Covid: Remdesivir
The question
To ask the Secretary of State for Health and Social Care, whether his Department has had discussions with the University of Derby on the development of the drug Remdesivir for the treatment of long Covid.
Answered by Ashley Dalton
We are aware of the University of Derby’s study looking at the use of the drug Remdesivir for the treatment of long COVID, however officials have not discussed the study with the research team. The study is being managed by the University of Plymouth’s Peninsula Clinical Trials Unit. Since 2008, the Department, through the National Institute for Health and Care Research, has funded clinical trials units in England to support developments in the design and delivery of efficient and innovative research. We will follow the progress of the study to understand the implications for policy and practice.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →